Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 10Rectal Neoplasms 9Pancreatic Neoplasms 8Cholangiocarcinoma 7Neoplasm Metastasis 6Carcinoma, Hepatocellular 6Vomiting 5Stomach Neoplasms 4Nausea 4Liver Neoplasms 4Esophageal Neoplasms 4Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Seminoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain, Postoperative 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mesothelioma 1Malnutrition 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Docetaxel 71Carboplatin 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 41Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Dexamethasone × Gastrointestinal × Clear all
NCT05319730 2026-05-26

MK-3475-06B

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting
230 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05070247 2026-01-22

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Takeda

Phase 1/2 Terminated
61 enrolled 29 charts
BreastGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Mesothelioma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT06643689 2024-11-14

TAPES

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
394 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

NCT01217060 2021-04-13

Trimodality Management of T1b Esophageal Cancers

M.D. Anderson Cancer Center

Phase 1/2 Completed
4 enrolled 8 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡